These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9002023

  • 1. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B, Gallati H, Erdi H, Gürler A, Michel BA, Villiger PM.
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [Abstract] [Full Text] [Related]

  • 2. Cytokines in Behçet's disease.
    Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroğlu IC, Dündar S, Kirazli S.
    J Rheumatol; 1996 Feb; 23(2):321-2. PubMed ID: 8882039
    [Abstract] [Full Text] [Related]

  • 3. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
    Turan B, Pfister K, Diener PA, Hell M, Möller B, Boyvat A, Ergin S, Villiger PM.
    Scand J Rheumatol; 2008 Feb; 37(2):135-41. PubMed ID: 18415772
    [Abstract] [Full Text] [Related]

  • 4. Hypersensitivity vasculitis and cytokines.
    Nalbant S, Koc B, Top C, Kucukardali Y, Baykal Y, Danaci M, Kocer IH.
    Rheumatol Int; 2002 Nov; 22(6):244-8. PubMed ID: 12426663
    [Abstract] [Full Text] [Related]

  • 5. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A.
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [Abstract] [Full Text] [Related]

  • 6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T, Fierz W, Stoll T, Villiger PM.
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [Abstract] [Full Text] [Related]

  • 7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C, Köse K, Caliş M, DemIr M, Kirnap M, Ateş F.
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [Abstract] [Full Text] [Related]

  • 8. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H.
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [Abstract] [Full Text] [Related]

  • 9. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
    Czelej D, Chodorowska G, Lechowska-Mazur I.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Apr; 58(1):38-42. PubMed ID: 15314956
    [Abstract] [Full Text] [Related]

  • 10. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 11. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
    Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A.
    Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 13. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
    Chodorowska G, Czelej D.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Feb; 58(1):43-7. PubMed ID: 15314957
    [Abstract] [Full Text] [Related]

  • 14. [The protective effects to the function of kidney and long by clearing of cytokines in patients with open-heart surgery].
    Zhang GH, Hou FF, Wang WJ, Zhang X, Wu H, Liu ZQ, Tao HQ.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3194-8. PubMed ID: 16405839
    [Abstract] [Full Text] [Related]

  • 15. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
    Park MC, Lee SW, Park YB, Lee SK.
    Rheumatology (Oxford); 2006 May 30; 45(5):545-8. PubMed ID: 16352633
    [Abstract] [Full Text] [Related]

  • 16. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoğdu M.
    Clin Rheumatol; 2005 Feb 30; 24(1):55-9. PubMed ID: 15338451
    [Abstract] [Full Text] [Related]

  • 17. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J.
    Neoplasma; 1999 Feb 30; 46(3):141-9. PubMed ID: 10613588
    [Abstract] [Full Text] [Related]

  • 18. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar 30; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 19. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP, Kuzański W, Andrzejewska E.
    Med Sci Monit; 2009 Jan 30; 15(1):CR26-31. PubMed ID: 19114968
    [Abstract] [Full Text] [Related]

  • 20. Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease.
    Riché F, Dosquet C, Panis Y, Valleur P, Laisné MJ, Briard C, Wautier JL.
    J Am Coll Surg; 1995 Jun 30; 180(6):718-24. PubMed ID: 7773486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.